45 related articles for article (PubMed ID: 31103263)
1. Human brain microvascular endothelial cells release different types of P-glycoprotein-containing extracellular vesicles upon exposure to doxorubicin.
Osten F; Löscher W; Gericke B
Toxicol Appl Pharmacol; 2023 Nov; 479():116712. PubMed ID: 37820772
[TBL] [Abstract][Full Text] [Related]
2. Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells.
Szebényi K; Füredi A; Bajtai E; Sama SN; Csiszar A; Gombos B; Szabó P; Grusch M; Szakács G
Drug Resist Updat; 2023 Nov; 71():101007. PubMed ID: 37741091
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of a zebrafish knockout model of abcb4, a homolog of the human multidrug efflux transporter P-glycoprotein.
Park J; Kim H; Alabdalla L; Mishra S; Mchaourab H
Hum Genomics; 2023 Sep; 17(1):84. PubMed ID: 37674192
[TBL] [Abstract][Full Text] [Related]
4. Biodynamic imaging for phenotypic profiling of three-dimensional tissue culture.
Sun H; Merrill D; An R; Turek J; Matei D; Nolte DD
J Biomed Opt; 2017 Jan; 22(1):16007. PubMed ID: 28301634
[TBL] [Abstract][Full Text] [Related]
5. Amphiphilic Cell-Penetrating Peptides Containing Natural and Unnatural Amino Acids as Drug Delivery Agents.
Salehi D; Mozaffari S; Zoghebi K; Lohan S; Mandal D; Tiwari RK; Parang K
Cells; 2022 Mar; 11(7):. PubMed ID: 35406720
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived cancer organoid tracking with wide-field one-photon redox imaging to assess treatment response.
Gil DA; Deming D; Skala MC
J Biomed Opt; 2021 Mar; 26(3):. PubMed ID: 33754540
[TBL] [Abstract][Full Text] [Related]
7. MARK2 enhances cisplatin resistance via PI3K/AKT/NF-κB signaling pathway in osteosarcoma cells.
Wei X; Xu L; Jeddo SF; Li K; Li X; Li J
Am J Transl Res; 2020; 12(5):1807-1823. PubMed ID: 32509178
[TBL] [Abstract][Full Text] [Related]
8. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic.
Dantzig AH; Law KL; Cao J; Starling JJ
Curr Med Chem; 2001 Jan; 8(1):39-50. PubMed ID: 11172691
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Doppler Spectroscopy detects altered drug response in SKOV3 tumor spheroids with silenced or inhibited P-glycoprotein.
Narayanan G; Merrill D; An R; Nolte DD; Turek JJ
Biochem Biophys Res Commun; 2019 Jul; 514(4):1154-1159. PubMed ID: 31103263
[TBL] [Abstract][Full Text] [Related]
11. Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif.
Ye S; MacEachran DP; Hamilton JW; O'Toole GA; Stanton BA
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C807-18. PubMed ID: 18650266
[TBL] [Abstract][Full Text] [Related]
12. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).
Jansson PJ; Yamagishi T; Arvind A; Seebacher N; Gutierrez E; Stacy A; Maleki S; Sharp D; Sahni S; Richardson DR
J Biol Chem; 2015 Apr; 290(15):9588-603. PubMed ID: 25720491
[TBL] [Abstract][Full Text] [Related]
13. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
Smith CD; Myers CB; Zilfou JT; Smith SN; Lawrence DS
Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
[TBL] [Abstract][Full Text] [Related]
14. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
[TBL] [Abstract][Full Text] [Related]
15. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
